Effectiveness and safety of intravenous tocilizumab to treat COVID-19-associated hyperinflammatory syndrome: Covizumab-6 observational cohort()

Although the starting event in COVID-19 is a viral infection some patients present with an over-exuberant inflammatory response, leading to acute lung injury (ALI) and adult respiratory distress syndrome (ARDS). Since IL-6 plays a critical role in the inflammatory response, we assessed the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Corominas, Hèctor, Castellví, Ivan, Pomar, Virginia, Antonijoan, Rosa, Mur, Isabel, Matas, Laia, Gich, Ignasi, de Benito, Natividad, Laiz, Ana, Castillo, Diego, Villamarin, Laura, Filella, David, Millán, Ana Milena, Quijada, María Ángeles, Puig, Mireia, Casademont, Jordi, Domingo, Pere
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658611/
https://www.ncbi.nlm.nih.gov/pubmed/33189888
http://dx.doi.org/10.1016/j.clim.2020.108631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7658611/
https://www.ncbi.nlm.nih.gov/pubmed/33189888
http://dx.doi.org/10.1016/j.clim.2020.108631

Ejemplares similares